The purpose of this study is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts on preventing graft loss. A prospective cohort of subjects will be compared to a historical control group in a non-inferiority trial.
Males and females, ages 3 months and older, with 20-60% total body surface area burns who are admitted to the Memorial Medical Center Regional Burn Center may be eligible.
Prospective participants will receive Sulfamylon® solution as topical antimicrobial treatment on moist dressings following the initial meshed autograft procedure. Assessments will be completed at various intervals during hospitalization, which will be compared to similar assessments of previously hospitalized burn patients who did not receive Sulfamylon®.
The study may take up to 3 weeks or less if discharged before 3 weeks.
Please contact Jennifer Koechle, MPH, at (217) 545-7014 or email email@example.com
Michael W. Neumeister, MD